Yi-Han Zuo1Quan-Bin Han3Geng-Ting Dong1Rui-Qi Yue3Xue-Cong Ren1Jian-Xin Liu1,4Liang Liu1
Pei Luo1*
Hua Zhou1,2*- 1State Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China
- 2International Institute of Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
- 3School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
- 4College of Pharmacy, Hunan University of Medicine, Huaihua, China
Background and Objective: Ischemic heart disease (IHD) has been the major issue of public health. Panax ginseng (ginseng) has been verified as an effective traditional Chinese medicines and exerted cardioprotective effect. This study aimed to investigate the polysaccharide fraction of ginseng on hypoxia/reoxygenation (H/R) injury in cardiomyocytes and the underlying mechanisms.
Methods: Ginseng was extracted by ethanol and fractionated by high-speed counter current chromatography (HSCCC) and column separation. The cardioprotective effect was evaluated in H9c2 cardiomyocytes underwent H/R treatment. The cell viability, apoptosis and mitochondrial respiration were examined.
Results: An acid polysaccharides fraction of ginseng (AP1) was identified the most effective fraction in protecting cardiomyocytes from H/R injury. AP1 restored the mitochondrial function by maintaining mitochondrial membrane potential (MMP), blocking the release of cytochrome C, and increasing the ATP generation and oxygen consumption rate (OCR) of cardiomyocytes. Meanwhile, AP1 induced the expression of glucocorticoid receptor (GR) and estrogen receptor (ER) which further activated reperfusion injury salvage kinase (RISK) pathway. Finally, AP1 increased nitric oxide (NO) production and regulated endothelial function by increasing endothelial NO synthase (eNOS) expression and decreasing inducible NOS (iNOS) expression in H/R injury.
Conclusion: The results suggested that AP1 exerted a protective effect in myocardial H/R injury mainly through maintaining myocardial mitochondrial function, thereby inhibiting myocardial H/R caused apoptosis and increasing the expressions of GR and ER, which in turn mediated the activation of RISK pathway and eNOS-dependent mechanism to resist the reperfusion injury.
Introduction
According to the reports of World Health Organization [WHO] in 2014, about 7.4 million people died of IHD, making IHD the No. 1 human killer (World Health Organization, 2014). The main factor leading to damage of myocardium in IHD is the deprivation of nutrients and oxygen caused by coronary occlusion, and the degree and duration of arterial obstruction decide the damage severity. Timely reperfusion can be used to reduce the mortality in the short term effectively, but in the long term, it can trigger cardiac remodeling as the reperfusion process is accompanied with additional oxidative stress and cardiomyocyte inflammation, etc. (Moens et al., 2005; Yellon and Hausenloy, 2007; Hausenloy and Yellon, 2013). Thus, to improve patients’ prognosis, it is important to prevent or limit the damage to the myocardium in the early phase of reperfusion.
For the prevention and control of reperfusion injury, functional foods would be a suitable choice because of less adverse effects when they are taken regularly (Shahidi, 2004; Castro et al., 2005). In TCM system, it is believed that food and medicine originate from the similar source but with different applications and purposes. Ginseng, an herbal root of Panax ginseng C.A. Meyer, has over 2,000 years history of extensive uses as TCM and functional supplements (Liu and Xiao, 1992; Attele et al., 1999; Lu et al., 2009). Numerous experimental evidences have suggested that ginseng extract exerts therapeutic effects with multiple cardiovascular activities, such as reducing myocardial infract size, regulating blood circulation and improving lipid profiles (Vogler et al., 1999; Kim and Park, 2003; Ahn et al., 2011; Zhou et al., 2011). Many of the pharmacological actions of ginseng extract are produced by ginsenosides which belong to a common type of glycosides, and have been demonstrated by intensively studied to possess a pivotal role in the pharmacological activities of ginseng (Chen, 1996; Lu et al., 2009; Jiang et al., 2014; Lee and Kim, 2014). When compared to the effect of ginsenosides, ginseng polysaccharides are largely underappreciated or even discarded. For instance, in modern industrialized TCM preparation, polysaccharides are commonly removed as impurities to reduce the dosage amounts of final products. Nevertheless, polysaccharides, obtained from the water-soluble fraction of ginseng, have been demonstrated with immuneregulatory, anti-oxidative, and anti-cancer effects, etc (Lim et al., 2004; Sun et al., 2014; He et al., 2015). Several reports have showed that polysaccharides isolated from Aralia elata (Zhang et al., 2013a,b), Ophiopogon japonicas (Shi et al., 2015; Wang et al., 2015), and Salvia miltiorrhiza had significant cardioprotective effects (Song et al., 2013; Chang et al., 2016). However, the effects of ginseng polysaccharides on cardiac injury have not been reported yet. Therefore, this study aimed to isolate the polysaccharides from ginseng by bioassay guided separation and to investigate whether it has cardioprotective effect and then explore the underlying mechanisms of cardioprotective effect of this substances.
Materials and Methods
Raw Materials and Extraction of Ginseng
The root of P. ginseng was purchased from the wholesale market in Jinlin Province, China. The quality of P. ginseng has been certified to meet the requirements of Hong Kong Standard of Chinese Materia Medica and Chinese Pharmacopeia. Samples were stored in the laboratory in the dry environment until use, and the voucher specimens of the whole roots were stored in the School of Chinese Medicine of Hong Kong Baptist University. The ginseng extract (RSE) was prepared by ethanol extraction, a well-developed and widely accepted approach for preparation of the ginseng extract, according to our previous report (Zhou et al., 2011).
Chemicals, Reagents, and Cell
The Millipore MILLI Q-Plus system (Bedford, MA, United States) was used to prepare deionized water. ACS grade methanol, chloroform, ethyl acetate and butanol were purchased from ACS Chemical, Inc. (Point Pleasant, NJ, United States). ACS grade ethanol, phenol, concentrated sulfuric acid, ammonia water, and sodium hydroxides were purchased from Merck (Darmstadt, Germany). TFA and ammonium acetate were bought from Riedel-de Haen (Morristown, NJ, United States). HPLC grade acetonitrile was purchased from RCL Labscan Limited (Bangkok, Thailand). Dextrans with different molecular mass, monosaccharide standards, Glc, Gal A, PMP, and sodium chloride were bought from Sigma (St. Louis, MO, United States).
Mitochondrial viability stain assay reagent was purchased from Abcam (Cambridge, England, Cat. ab129732). DZ was obtained from Sigma (St. Louis, MO, United States). FBS, trypsin, DMEM, and glucose-free DMEM were bought from Gibco (Carlsbad, CA United States). Griess reagent, inhibitors of phosphoinositide 3-kinase (PI3K, LY29002), ER (tamoxifen), endothelial nitric oxide (eNOS, L-NAME), p-ERK1/2 (U0126) and GR (mifepristone), and the Akt inhibitor IV were purchased from Sigma–Aldrich (St. Louis, MO, United States). All of other reagents were of analysis grade and purchased from the market.
H9c2 cell line derived from rat ventricular muscles was purchased from ATCC (Rockville, MD, United States). The cells were cultured in DMEM filled with 100 μg/mL of streptomycin, 100 U/mL of penicillin and 10% FBS in the normoxic condition (95% air/5% CO2) at 37°C. The medium was changed every 2 days, and confluent cells were passaged in a trypsinized way every week. The cells with three to four times of passaging were used in this research.
High-Speed Counter-Current Chromatography Separation
The ginseng extract was fractionated by using high-speed counter-current chromatography (HSCCC) first. A TBE-1000A HSCCC system produced by Tauto Bio-technique Company (Shanghai, China) with a three-polyterafluoroethylene coil with 1000 mL total capacity was adopted. The β value of the column from internal layer to external layer varied from 0.59 to 0.75. A Waters HPLC instrument equipped with 2425 pump, 2489 UV detector, Flex Inject injector and Fraction Collector III (Waters Corp., Milford, MA, United States) was connected to the HSCCC instrument. The preparation of the diphase solvent system included adding solvents into a separating funnel by the volume ratio and then shaking the solvents in a repeated way at room temperature to fully equilibrate the solvents. After being separated and degassed by sonication, the upper and lower phases stood still overnight prior to usage. After being dissolved in 60 mL of two-phase solvents, the ginseng extract (4.12 g) was centrifuged with a Centrifuge 5810 (Eppendorf, Hamburg, Germany) at 4000 rpm for 15 min, so that supernatant solution can be prepared. Then, the stationary phase, i.e., the upper phase of butanol-water (1:1) was filled in the HSCCC column which was then rotated in the clockwise direction at 800 rpm and filled with the sample solution via an injection loop. Next, the lower layer of butanol-water at a ratio of 1:1 was injected into the HSCCC column thoroughly at 8 mL/min. When the separation time ran to 100 min, the mobile phase was changed to lower phase of ethyl acetate-water (1:1). The effluent in each 5 min was collected as a fraction. Based on the silica gel TLC examination results, the fractions were combined and then freeze dried. The mobile phase of TLC composed of water, methanol and chloroform by ratio of 2:7:13, an UV-254 nm was used to detect TLC. The bioactivity of different HSCCC fractions were examined in H9c2 cardiomyocytes exposed to H/R according to the method described in section “Hypoxia/Reoxygenation and Drug Treatment.”
Stepwise Ethanol Precipitation
The HSCCC fractions with bioactivity were dissolved in water and further fractionated using stepwise precipitation in 90, 80, and 70% of ethanol solutions successively. Supernatants and precipitates at each precipitation were separated and collected via centrifugation and lyophilization and then examined for their bioactivity by using the method described in section “Hypoxia/Reoxygenation and Drug Treatment.”
Ion-Exchange Chromatography
The final precipitation in section “Stepwise Ethanol Precipitation” was separated by anion-exchange chromatography on Toyopearl DEAE 650 M (Sigma–Aldrich, St. Louis, MO, United States) which was step wisely eluted with H2O, 0.5 M of NaCl, 1.0 M of NaCl, 2.0 M of NaCl and 0.2 M of NaOH to give five fractions, namely, neutral polysaccharides (NP), acidic polysaccharides (AP) 1, AP2, AP3, and AP4. These five fractions were separately dialyzed against 1000 Da sieve (Wako, Osaka, Japan) in water for 24 h, then centrifuged and lyophilized. The bioactivity of the five fractions was examined by using the method described in section “Hypoxia/Reoxygenation and Drug Treatment.”
Characterization of Polysaccharides
The apparent molecular weight of the active polysaccharides fractions was determined by using HPGPC. The monosaccharide composition was analyzed by HPLC using the reported methods (Xu et al., 2014). The total sugar contents were determined by phenol-H2SO4 colorimetric method (Dubois et al., 1956). The content of uronic acid was determined by using m-hydroxydiphenyl method (Blumenkrantz and Asboe-Hansen, 1973). Protein was determined by Bradford assay.
Cell Viability
The cell viability was examined with MVS assay. In brief, when cell culture was finished, each well of H9c2 cells with 100 μL of medium was overlaid with 2× mitochondrial viability stain (100 μL), and then the cells were put in the incubator with the normoxic environment (95% air/5% CO2) at 37°C for 4 h in the dark. The fluorescent intensity was measured by a Tecan Infinite M200 microplate reader (Tecan, Durham, NC, United States) at excitation 550 nm and emission 590 nm. The cell viability was calculated as the percentage OD value of tested cells over controlled cells.
Hypoxia/Reoxygenation and Drug Treatment
Hypoxia/reoxygenation treatment was achieved by using a hypoxic chamber (Stem Cell Technologies, United States) to create a challenge of in vitro hypoxia environment as described by us previously (Dong et al., 2016). In brief, the cells were firstly cultured in DMEM under normoxic environment (95% air/5% CO2) at 37°C overnight, then washed twice with KRB buffer (composition in mM: NaCl 115, KCl 4.7, CaCl2 2.5, KH2PO4 1.2, MgSO4 1.2, NaHCO3 24, HEPES 10; pH 7.4) prebalanced with N2 at 4°C overnight. Next, 100 μL of KRB and 0.01% (w/v) BSA were added in each well. Then, the cells were placed in the chamber and flushed with pure N2 for 5 min at a flow rate of 20 mL/min, all connectors of the chamber were then closed and sealed. The cells with the chamber was then moved into an incubator for a hypoxic culture at 37°C for 3 h. After the hypoxia incubation, KRB in each well was replaced with fresh DMEM, and the cells were incubated for another 4 h in the normoxic condition (95% air/5% CO2) at 37°C without chamber.
Drug Treatment
The bioactivity of different ginseng fractions was examined with H9c2 cells in a density of 8 × 103/100 μL/well seeded in a 96-well plate or 2 × 104/2 mL μl/well seeded in a 6-well plate. The tested samples were added to the cells 1 h before hypoxia treatment and remained in the whole H/R process. The normal control cells (Normal) were cultured in DMEM in normoxic environment (95% air/5% CO2) at 37°C for 8 h in parallel with the manipulation of H/R treatment. To explore the roles of different kinases in the effect of AP1, the cells were pretreated with 40 μM of U0126 (Erk1/2 inhibitor), 10 μM of Akt inhibitor IV (Akt inhibitor), 40 μM of LY294002 (PI3K inhibitor), 10 μmol/L of L-NAME (eNOS inhibitor), 100 μM of tamoxifen (ER inhibitor) and 100 μM of mifepristone (GR inhibitor) (Turner et al., 2000; Khan et al., 2002; Park et al., 2003; Dunn et al., 2009; Buontempo et al., 2011; Todd et al., 2014) for 1 h prior to AP1 (200 μg/mL) treatment.
Measurement of Lactate Dehydrogenase and Creatine Kinase Activities
After H/R injury, the cell culture medium was collected for the measurement of LDH and CK activities by using commercial assay kits (Roche, Switzerland or Biovision, United States) according the methods recommended by the manufacturer using a spectrophotometer detected at 450 and 660 nm, respectively.
Measurement of Intracellular Malondialdehyde Level and Superoxide Dismutase Activity
After H/R injury, the cellular protein was extracted and quantified using the bicinchoninic acid (BCA) method. Then, the intracellular protein was used to measure MDA level at 532 nm and superoxide dismutase activity (SOD) activity at 450 nm by using commercial assay kits (Beyotime Institute of Biotechnology, Beijing, China) according the methods recommended by the manufacturer.
Measurement of Intracellular ROS and Mitochondrial ROS
The intracellular and mitochondrial ROS level was measured with DCFH-DA probe or mitoSOX as previously reported method with modification (Zhang et al., 2015). In brief, after H/R injury, the cell pellets were collected and cleansed with serum-free media. Then, the cells were mixed with serum-free media containing 10 μM DCFH-DA probe (Molecular Probes, Eugene, OR, United States) or 5 μM mitoSOX (Thermo Fisher Scientific, Waltham, MA, United States) and stayed at 37°C in darkness for 30 min with slight agitation every 5 min. Then, the cell pellets were collected and cleansed in PBS for three times, and suspended in 500 μL PBS for flow cytometry analysis on BD FACSAria III (BD Biosciences, Franklin Lakes, NJ, United States). The induced wavelength of the green fluorescence sent from 10,000 cells was documented at 488 or 510 nm. The Flow J software was used to analyze the average intensity of fluorescence.
Western Blot Analysis
After H/R injury, the cell pellets were collected and cleansed with cold PBS for two times. To determine the release of cytochrome C from mitochondria to cytosol, the extraction of cell cytosolic and mitochondrial fractions were performed using the Cell Mitochondria Isolation Kit (Thermo Fisher Scientific, Waltham, MA, United States). Total cell proteins were extracted by RIPA lysing buffer (1% Nonidet P-40, 1% sodium deoxycholate, 0.5% SDS, 150 mM NaCl, pH 7.5) for 20 min, then centrifuged at 14,000 g and 4°C for another 20 min, the supernatants were collected and stored at -80°C. The protein concentration was measured by a Bradford Protein Assay Kit (Bio-Rad, Hercules, CA, United States). Same quantities (40 μg) of protein were loaded and separated on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and then conveyed to a nitrocellulose membrane. The membranes in Tris-glycine buffer were plugged with 5% of skim milk powder in saline [with 0.1% (v/v) Tween-20] buffered with Tris-glycine at room temperature for 1 h, incubated with the primary antibodies of p-JNK, JNK, p-p38, p38, p-ERK, ERK, GR, p-PI3K, PI3K, p-Akt, Akt, inducible NOS (iNOS), cytochrome c, Bcl-2, Bax (Cell Signaling Technology, Boston, MA, United States), ER, p-eNOS, eNOS, β-actin (Santa Cruz Biotechnology, Santa Cruz, CA, United States) and COX IV (Abcam, Cambridge, MA, United States) at 4°C overnight, and then the secondary antibodies conjugated with IRDye (LI-COR Biosciences, Belfast, ME, United States) for 1 h at room temperature. The Odyssey CLx Imaging System (Li-COR Biosciences, Belfast, ME, United States) were used to obtain the band of the antigen-antibody complex and the Odyssey v3.0 software was employed for the densitometric analysis to obtain band intensity.
Measurement of Nitric Oxide
After H/R injury, the cell culture medium was collected for measuring the level of nitric oxide (NO) by using the Griess reaction according to the reported method (Chen et al., 2012) using a commercial kit of Promega (Madison, WI, United States). Briefly, the cell culture medium (40 μL) was mixed with NADPH (1 mM, 10 μL) and a basic solution (composed of 1.25 mM of glucose-6-phosphate, 0.03 M of PBS, 400 U/L of glucose-6-phosphate dehydrogenase and 200 U/L of nitrate) and stayed at room temperature for 45 min. Then, the Griess reagent (50 μL) added to the mixture and stayed at room temperature in darkness for 20 min. Finally, the absorbance of the mixture was measured at 540 nm. The level of NO was calculated according to the instruction of the kit.
Apoptosis Analysis With Flow Cytometer
A FITC Annexin V Apoptosis Detection Kit (BD, Franklin Lakes, NJ, United States) was employed to measure the percentage of apoptotic cells according to the manufacturer’s instructions. In brief, the cells exposed to H/R injury were washed with PBS and suspended in 1 × binding buffer containing FITC-labeled Annexin V and propidium iodide. After standing in darkness at room temperature for 15 min, the cell suspension was analyzed on BD FACSAria III (BD Biosciences, Franklin Lakes, NJ, United States). The induced wavelength of the green fluorescence sent from 10,000 cells was documented at 488 nm. The Flow J software was used to analyze the percentage of apoptotic cells.
Determination of Caspase Activity
The activity of Caspase -3/7 and -9 were measured as described previously (Lu et al., 2010) using a Caspase-Glo assay kit (Promega, Madison, WI, United States). In brief, caspase-3/7 reagent (100 μL/well) or caspase-9 reagent (100 μL/well) was added to the cells after H/R injury and incubated in darkness for 1 h on a shaker at room temperature. Then, the luminescence was determined with a Tecan Infinite M200 microplate reader (Tecan, Durham, NJ, United States).
Measurement of Mitochondrial Membrane Potential
The MMP was measured using rhodamine 123 (Molecular Probes, Eugene, OR, United States) according to the reported method (Joshi and Bakowska, 2011). In brief, the cells exposed to H/R injury were washed with PBS, added with rhodamine 123 (final concentration 10 μM), and kept at 37°C for 30 min in darkness. The fluorescence of cells cultured in 6-well plate was observed with a DeltaVision Elite Cell Imaging System (Applied Precision Inc., GE Healthcare Company, United States), the luminescence of cells cultured in 96-well plate was determined with a Tecan Infinite M200 microplate reader (Tecan, Durham, NC, United States).
Determination of ATP Level
The ATP level was determined with an ATP measurement detection assay kit (Abcam, United States) according to the manufacturer’s instructions. Briefly, the cells exposed to H/R injury were incubated with ATP substrate solution (100 μL/well) in darkness for 5 min on a shaker at room temperature. The luminescence of each well was determined with a Tecan Infinite M200 microplate reader (Tecan, Durham, NC, United States).
Evaluation of Oxygen Consumption Rate
Mitochondrial respiration is a strong indicator of the functional bioenergetics capacity of mitochondria and overall cellular health. OCR is an index of cellular oxygen consumption and can used to reflect the mitochondrial respiration. In this research, OCR was evaluated by XFp Extracellular Flux Analyzer (Seahorse Biosciences, North Billerica, MA, United States) in accordance with a modified protocol as previously described (Duicu et al., 2015). In brief, the cells were seeded in Seahorse XFp cell cultured miniplates in 5000 cells/well and subject to H/R treatment. One day before the experiment, the sensor cartridge of an XFp analyzer was hydrated in the non-CO2 incubator at 37°C. The XF assay medium 2.5 M glucose, not buffered and supplied by Seahorse Biosciences was used to replace the incubation medium. To form the baseline rate, the OCR rate was measured at all time and then the metabolism of cells was put in a challenge (for the purpose of changing their bioenergetics profiles) incurred by adding three solutions: 10 μM oligomycin (complex V inhibitor), 2 μM FCCP, and 0.5 μM antimycin A/Rotenone (inhibitors of complex I and III). The wells without cell seeding was used to correct background and normalize the reading of each well to the background plate noise. OCR was normalized for total protein per well and expressed as pmol/min/μg protein.
Statistic Analysis
One-way ANOVA was used to analyze the statistical significance among different groups with the Graph Pad Prism 6.0 software (Graph Pad Software Inc., La Jolla, CA, United States). P < 0.05 was regarded as statistically significant. All measurements were repeated in 3∼6 wells in each experiment, the results were obtained from 3 independent experiments.
Results
Bioassay-Guided Separation of Ginseng Extract
After HSCCC separation of 4.12 g of ginseng extract, the elution was collected in 48 tubes. After separation, the HSCCC column still had 1000 mL solution, including the lower phase and the upper phase, and such solution was squeezed out due to the high-pressure gasses, so that the last two fractions were obtained. These fractions were combined to nine fractions according to the similarity in their TLC pattern (Figure 1A). The total recovery was 94.36%. Besides small polysaccharides (MW < 1800 Da), high polymeric polysaccharides whose molecular weights varying from 1800 Da to 10.6 × 105 Da were also found as the major components (Figure 1B).
FIGURE 1. Bioassay guided fractionation of cardioprotective components from ginseng extract. (A) The TLC spectrum of the 50 fractions of ginseng extract in HSCCC separation. The TLC spectrum of fraction 1–17 of ginseng extract (1); The TLC spectrum of fraction 18–34 of ginseng extract (2); The TLC spectrum of fraction 35–50 of ginseng extract (3). (B) Molecular weight distribution of ginseng extracts 2 and 3. (C) Protective effects of ginseng extracts in H9c2 cells exposed to H/R injury. (D) Protective effects of fractions of ginseng extract 2/3 in H9c2 cells exposed to H/R injury. (E) Protective effects of five fractions of total 70% ethanol precipitates fraction in H9c2 cells exposed to H/R injury. (F) Molecular weight distribution of AP1. (G) Cytotoxicity of AP1 in H9c2 cells under normoxic conditions. MVS assay was employed to measure cell viability. The results are presented as a percentage of normal group. Data are presented in mean ± SD of three independent experiments. N = 3. (C–E) ˆ ˆ ˆ P < 0.001 vs. Normal, ∗∗P < 0.01 vs. H/R, ∗∗∗P < 0.001 vs. H/R, (G) ∗∗∗P < 0.001 vs. Normal.
Next, the cardioprotective effects of these nine fractions were examined. Among them, fractions 2 and 3 were demonstrated to be the most effective fractions (Figure 1C) that exhibited identical molecular distribution pattern as revealed by HPGPC. Further stepwise ethanol precipitation of fractions 2/3 mixtures (1:1, 0.74 g) was performed, this offered 4 smaller fractions. Among these four fractions, the precipitate generated from precipitation in 70% ethanol exhibited the strongest activity (Figure 1D) and was further subjected onto ion-exchange column chromatography on Toyopearl DEAE 650 M. After isolation, five fractions were collected, and named NP, AP1, AP2, AP3, and AP4. After dialysis and lyophilization, they accounted for 28.96, 39.39, 5.24, 1.37, 1.12% of total 70% ethanol precipitates fraction, respectively. The total recovery was 76.15%. Among them, AP1 was testified as the major fraction, presenting the highest efficacy in preventing cardiomyocytes from death (Figure 1E). Thus, AP1 fraction was selected for further study as the effective constituent of ginseng for cardioprotection.
Chemical Characterization and Cytotoxicity of AP1
Principal components analysis identified that 90.28% of AP1 was carbohydrate composition. Its uronic acid content was 17.93% (w/w), while the protein content was 9.85%. The apparent molecular weight of AP1 was estimated to be 3.8 × 104 (Figure 1F). Carbohydrate composition analysis revealed that AP1 was mainly composed of Glc (76.31%), Gal (12.70%) with small amount of Gal A (5.64%), Ara (3.72%), Glc A (1.64%). Based on these results, AP1 was characterized as acidic heteroglycan. Furthermore, the cytotoxicity of AP1 to normal H9c2 cells was tested under normoxic environment. Pretreatment of AP1 at concentrations of 6.25–800 μg/mL for 24 h didn’t cause cytotoxicity to H9c2 cardiomyocytes (Figure 1G).
Cardioprotective Effect of AP1 in H9c2 Cardiomyocytes
The cardioprotective effect of AP1 against H/R injury was investigated in H9c2 cells by morphological observation and MVS assay at first. Normally, H9c2 cardiomyocytes adhered to the plate uniformly in a filamentous shape as reported (Sardao et al., 2009). When exposed to hypoxia for 3 h and followed by reoxygenation for 4 h, the cells became round or irregular shapes, indicating the cytotoxic effect of H/R injury (Figure 2A). However, AP1 at 200 μg/mL largely retained the normal shape of cardiomyocytes. The cell viability of H/R group significantly decreased (Figure 2B, P < 0.001, vs. Normal control). DZ, a mitochondria potassium channel opener (Janjua et al., 2014) that was potent in protecting hearts and cardiomyocytes from I/R injury (Henn et al., 2015), was used as positive control and showed significant protection to the cell at 100 μM (Figure 2B, P < 0.001, vs. H/R). AP1 pretreatment dose dependently increased the viability of H9c2 cell exposed to 3 h hypoxia and 4 h reoxygenation (Figure 2B, P < 0.001, vs. H/R). AP1 at even a very low dose (12.5 μg/mL) still produced protective effect. AP1 at 200 μg/mL produced the best protective effect among the dosages examined and was better than the general extract of ginseng RSE (200 μg/mL), showing AP1 is one of the major active constituent of RSE and ginseng. If the dosage further increased to 400 or 800 μg/mL, AP1 although still had protective effect, the potency decreased a little compared with 200 μg/mL, implying the appearance of potential cytotoxicity. Therefore, the highest dosage of AP1 used in other experiment was 200 μg/mL.
FIGURE 2. Effect of AP1 on cell viability and apoptosis induced by H/R injury in H9c2 cardiomyocytes. (A) Effect of AP1 on cell morphology of H9c2 cells exposed to H/R. 100 μM of DZ was adopted as positive control. The normal control cells were always cultured in DMEM in normoxic environment in parallel with the manipulation of H/R treatment. (B) Dose-response relationship of AP1 on cell viability measured by MVS assay. (C,D) Effect of AP1 on LDH and CK activities in H9c2 cells exposed to H/R. (E,F) Effect of AP1 on the apoptosis of H9c2 cells exposed to H/R. Flow cytometry was used to detect inhibition of H/R-induced cell apoptosis by AP1 under assistance of PI and Annexin V-FITC. Cells in Q4 were living cells, in Q2 were late apoptotic cells, and in Q3 were early apoptotic cells. (G) Effect of AP1 on the activity of caspase -3/7 and -9 in H9c2 cells exposed to H/R. The results are presented as a percentage compared to the normal group. Data are presented in mean ± SD of three independent experiments. N = 3. ˆˆˆP < 0.001 vs. Normal, ∗P < 0.05 vs. H/R, ∗∗P < 0.01 vs. H/R, ∗∗∗P < 0.001 vs. H/R, ###P < 0.001 vs. RSE.
The loss of cell membrane integrity caused by H/R injury results in the release of LDH and CK, indicators of myocardium injury and terminal apoptotic cells. AP1 pretreatment dose dependently and remarkably decreased the elevated activities of LDH and CK induced by H/R (Figures 2C,D, P < 0.05∼0.001). Considering the importance of apoptosis in determining cell death after ischemia/reperfusion, anti-apoptotic effect of AP1 was assessed. Annexin V/PI double staining showed that the apoptosis of H/R group increased sharply (Figure 2E, P < 0.001 vs. Normal). However, AP1 and DZ remarkably reversed this, showing by significant attenuation of H/R induced apoptosis (Figure 2F, P < 0.05∼0.001 vs. H/R). Caspase-3/7 and caspase-9 are important apoptotic indicators in the apoptotic pathway relied on mitochondria (Li et al., 1997; Porter and Janicke, 1999). Thus, the effect of AP1 on the activities of caspase-3/7 and caspase-9 in H9c2 cells with H/R injury was examined. H/R induced significant increase in the activities of caspase-3/7 and caspase-9 in H9c2 cells exposed to H/R (Figure 2G, P < 0.001, vs. Normal). However, AP1 at 50 and 200 μg/mL and DZ at 100 μM reduced the activities of caspase-3/7 and caspase-9 (Figure 2G, P < 0.05∼0.001, vs. H/R), showing that the caspase-dependent apoptotic pathway plays a role in the cardioprotective effect of AP1.
These results suggested that AP1 had obvious cardioprotective effect to H9c2 cell against H/R induced injury through the reduction of apoptosis.
AP1 Protected H9c2 Cells From H/R Injury by Reduction of Oxidation and Reactive Oxygen Species Mediated JNK/p38-MAPK Activation
Evidences suggest that overproduction of ROS impairs mitochondrial function, which leads to further reperfusion toxicity (Takano et al., 2003). Considering cellular ROS release plays an important role in the activation of the preconditioning protection in the cardiovascular system (Becker, 2004), the effect of AP1 on the intracellular level of ROS was examined so as to inspect the association between the release of intracellular ROS and cardioprotection of AP1. As shown in Figures 3A,C, H/R induced significant release of intracellular ROS, showing by the increased fluorescence intensity (P < 0.001 vs. Normal). However, the intracellular ROS levels dramatically dropped down by the pretreatment of AP1 in a dose dependent manner (P < 0.05∼0.001 vs. H/R). In addition, since mitochondrial ROS (mitoROS) is the most important source of the intracellular ROS (Kalogeris et al., 2014), to understand the effect of AP1 on the mitoROS production, we compared the mitoROS production of H9c2 cell underwent H/R with or without AP1 treatment. The results showed that H/R caused the elevation of mitoROS production, while AP1 pretreatment suppressed this elevation (P < 0.05∼0.001 vs. H/R) (Figures 3B,C).
FIGURE 3. Effect of AP1 on oxidation and ROS production in H9c2 cells exposed to H/R. (A) Effect of AP1 on intercellular ROS formation. (B) Effect of AP1 on mitochondrial ROS formation. (C) Quantification of intracellular and mitochondrial ROS. (D) Effect of AP1 on MDA contents. (E) Effect of AP1 on SOD activity. (F,G) Effect of AP1 on phosphorylation of p38 and JNK. Data are presented in mean ± SD of three independent experiments. ˆ ˆ P < 0.01 vs. Normal, ˆˆˆP < 0.001 vs. Normal, ∗P < 0.05 vs. H/R, ∗∗P < 0.01 vs. H/R, ∗∗∗P < 0.001 vs. H/R.
In addition, the concentration of myocardial MDA, a byproduct of ROS reflecting myocardial oxidative damage (Gago-Dominguez et al., 2002), and the activity of SOD that is a main source of ROS scavenger (Nishikawa et al., 2000) were also evaluated. As shown in Figures 3D,E, H/R significantly induced increase of MDA level and decrease of SOD activity. Nevertheless, AP1 treatment dose dependently recovered the change of MDA level and SOD activity caused by H/R (P < 0.05∼0.001, vs. H/R).
As an early signal of apoptosis, ROS also directly involves in the activation of JNK and p38 signaling (Benhar et al., 2001; Shen and Liu, 2006), which play an indispensable role in oxidative stress induced apoptosis (Xia et al., 1995). Therefore, the change of these signaling proteins in H/R injury was investigated. As shown in Figures 3F,G, H/R induced phosphorylation of p38 and JNK without influencing the total p38 and JNK; while AP1 pretreatment significantly inhibited the phosphorylation of JNK and p38 induced by H/R in a dose-dependent manner (P < 0.05∼0.001, vs. H/R).
These results suggested that AP1 protected H9c2 cells from H/R injury by reduction of oxidation and ROS mediated JNK/p38-MAPK activation.
AP1 Effectively Alleviated Mitochondrial Dysfunction Caused by H/R Injury
Mitochondrial dysfunction is a major consequence of H/R injury and MMP is a direct indicator of mitochondrial respiration efficiency (Petrosillo et al., 2009). Therefore, the MMP of H9c2 cell was measured. As shown in Figure 4A, H/R injury caused a significantly decreased uptake of Rh123, showing the dissipation of MMP (Figure 4B, P < 0.001 vs. Normal). Interestingly, the loss of MMP was ameliorated by pretreatment of AP1 (Figures 4A,B, P < 0.01 vs. H/R), implying that AP1 preserved the mitochondrial function of cardiomyocytes exposed to H/R.
FIGURE 4. Effect of AP1 on the mitochondrial functions of H9c2 cell exposed to H/R. (A,B) Effect of AP1 on MMP (mitochondrial membrane potential). (C) Effect of AP1 on Bcl-2/Bax ratio. (D) Effect of AP1 on cytochrome c in mitochondria and the cytoplasm. COX IV was used as an internal loading control for mitochondrial proteins. (E) Effect of AP1 on ATP generation. (F,G) Effect of AP1 on OCR. The results are presented as a percentage compared to the normal group. Data are presented in mean ± SD of three independent experiments. ˆ P < 0.05 vs. Normal, ˆ ˆ P < 0.01 vs. Normal, ˆ ˆ ˆ P < 0.001 vs. Normal, ∗P < 0.05 vs. H/R, ∗∗P < 0.01 vs. H/R, ∗∗∗P < 0.001 vs. H/R.
Furthermore, according to earlier researches, the potential of cellular apoptosis is decided by expression of Bcl-2 and Bax (Yang et al., 1997). Besides, the Bcl-2 to Bax ratio is important for maintaining the integrity of mitochondrial membrane. Therefore, the expression of Bcl-2 and Bax in H9c2 cells exposed to H/R treatment was examined. The results showed (Figure 4C) that H/R treatment remarkably reduced the expression of Bcl-2 but increased the expression of Bax, causing a significant decrease of Bcl-2 to Bax ratio. However, AP1 at 200 μg/mL slightly reversed the decease of Bcl-2 and increase of Bax, causing an increase of Bcl-2 to Bax ratio in H9c2 cells exposed to H/R treatment (P < 0.05 vs. H/R).
The activation of intrinsic apoptosis is imitated by the release of cytochrome C from mitochondria to cytosol, therefore the level of cytochrome C in cytoplasm was also determined. The results (Figure 4D) showed that H/R treatment caused a remarkable release of cytochrome C to cytoplasm in H9c2 cells but decreased its level in mitochondria. However, pretreatment with AP1 dose dependently and significantly reduced the release of cytochrome C. The positive control drug DZ at 100 μM also showed the same effect. In addition, the generation of intracellular ATP levels was evaluated. The exposure of H9c2 cells to H/R significantly inhibited ATP generation (Figure 4E, P < 0.001 vs. Normal). This inhibition was reversed by AP1 and DZ (P < 0.05∼0.01 vs. Normal).
To further interrogate the mitochondrial metabolic state of H/R injured H9c2 cells, the mitochondrial respiration was evaluated by measuring OCR in Seahorse XFp Extracellular Flux Analyzer. As shown in Figures 4F,G, the basal respiration (OCR before addition of oligomycin), ATP production (the decrease in OCR following addition of oligomycin), maximal respiration (OCR after addition of FCCP), spare respiratory capacity, were significantly lower in the H/R injured cells than in the normal group (P < 0.01), indicating that H/R decreased the energetic demand under baseline conditions, ATP production, maximal capacity of respiratory oxidation, and cell flexibility of H9c2 due to damage of mitochondria. However, AP1 reversed these changes caused by H/R (P < 0.05), indicating that AP1 reserved the mitochondrial respiration in H9c2 cardiomyocytes exposed to H/R probably by protecting mitochondria from damage or dysfunction due to H/R.
AP1 Offered Cardioprotection Against Cell Death via RISK Signaling Pathway
Modulation of RISK pathway (consisting of PI3K/Akt and ERK1/2) by both ischemic preconditioning and postconditioning confers powerful protection to heart exposed to ischemia/reperfusion insult (Davidson et al., 2006; Hausenloy and Yellon, 2007; Kalakech et al., 2014). Our previous research had showed that stimulation of RISK pathway by ginseng extract through GR and ER protected heart from I/R injury in an eNOS dependent manner (Zhou et al., 2011). In this research, the role of GR, ER, RISK pathway, NOS, and NO in the effect of AP1 was also examined. As shown in Figure 5, H/R significantly suppressed the expressions of GR and ER (P < 0.001 vs. Normal). However, AP1 pretreatment remarkably and partially restore the expressions of GR and ER in H/R injured cells (P < 0.05∼0.01 vs. H/R). Similarly, positive control drug DZ also partially reversed the expressions of GR and ER (P < 0.05∼0.01 vs. H/R). Figure 5 shows that H/R didn’t change the expression of total PI3K, Akt, ERK1/2, eNOS, but significantly inhibited the phosphorylation of PI3K, Akt, and eNOS and significantly increased the expression of iNOS and phosphorylation of ERK1/2 (P < 0.05∼0.001); while AP1 pretreatment remarkably restored the phosphorylation of PI3K, Akt, and eNOS, further enhanced the phosphorylation of ERK1/2 in H/R injured cells, and suppressed the expression of iNOS (P < 0.05∼0.001 vs. H/R). This mechanism of AP1 is similar to that of ginseng extract RSE, implying that AP1 is a major constituent responsible for the cardioprotective effect of ginseng.
FIGURE 5. Effect of AP1 on GR, ER/RISK/eNOS pathway of H9c2 cell exposed to H/R. (A) Western-blot analysis was performed by the antibody specific to GR, ER, ERK1/2 or phosphorylated ERK1/2, PI3K or phosphorylated PI3K, Akt or phosphorylated Akt, eNOS or phosphorylated eNOS and iNOS. (B) Quantitative analyses for protein expression. Data are presented in mean ± SD of three independent experiments. ˆ P < 0.05 vs. Normal, ˆˆˆP < 0.001 vs. Normal, ∗P < 0.05 vs. H/R, ∗∗P < 0.01 vs. H/R, ∗∗∗P < 0.001 vs. H/R.
Cardioprotective Effect of AP1 Is Dependent on GR, ER, ERK1/2, PI3K and Akt
The above research suggested that AP1 may act on GR and ER to activate RISK pathway and eNOS and suppress iNOS thus protect cardiomyocytes from H/R injury. To confirm the role of these molecules in the effect of AP1, the cells were pretreated with the inhibitor of NOS (L-NAME), ERK1/2 (U0126), Akt inhibitor IV, PI3K (LY294002), ER (tamoxifen) or GR (mifepristone), and then the effect of AP1 on cell viability was examined. As shown in Figure 6A, these inhibitors didn’t change the cell viability of normal H9c2 cells and H/R treated cells, indicating that these inhibitors have no significant influence on the growth and cellular activities of H9c2 cell under normoxic and H/R conditions. However, these inhibitors significantly abolished the protective effect of AP1 on H9c2 cell (P < 0.01∼0.001 vs. AP1 alone in H/R insulted cells), implying that the cardioprotective effect AP1 requires the participation of eNOS, ERK1/2, Akt, PI3K, ER and ER.
FIGURE 6. Influence of different pharmacological inhibitors on the effect of AP1 on H9c2 cell exposed to H/R. (A) The H9c2 cells were cultured with or without mifepristone (MP, 100 μM), tamoxifen (TX, 100 μM), L-NAME (LM, 10 μmol/L), LY294002 (LY, 40 μM), Akt inhibitor IV (IV, 10 μM), U0126 (40 μM) first, then treated with or without 200 μg/mL AP1, finally exposed to H/R injury. The normal group was always maintained in normoxic condition. Cell death was assessed by MVS assay. (B,C) Effects of signaling inhibitors on eNOS protein level and NO production in H/R-stimulated H9c2 cells. Proteins were subjected to immunoblot analysis using antibodies specific to eNOS or p-eNOS (B). After incubation, nitrite in the culture supernatants was determined by a Griess assay (C). The results are presented as a percentage compared to the normal group. Data are presented in mean ± SD of three independent experiments. ˆˆˆP < 0.001 vs. Normal, ∗∗∗P < 0.001 vs. H/R, ##P < 0.01 vs. AP1+H/R, ###P < 0.001 vs. AP1+H/R, &&&P < 0.001 vs. AP1 (200 μg/mL + H/R).
Effects of AP1 on NO Production
Nitric oxide is an important factor in affecting the physiology and pathology of the cardiovascular system (Loscalzo and Welch, 1995; Burwell and Brookes, 2008; Shumilova et al., 2014). The above research showed that eNOS is indispensable to the cardioprotective effect of AP1, the NO level is therefore determined as well. As shown in Figure 6C, H/R induced significant decrease of NO production in H9c2 cells (P < 0.05 vs. Normal), agreeing the decreased phosphorylation of eNOS (Figure 5). AP1 and DZ pretreatments recovered the production of NO in H9c2 cells exposed to H/R injury. Interestingly, the change of NO level seems in parallel with the cell viability (Figure 6C), i.e., the higher the NO level the larger the cell viability. However, L-NAME (NOS inhibitor) completely suppressed the effect of AP1 on NO production, which is accompanied with the completely loss of protection to H9c2 cells (Figure 6A), implying that eNOS dependent NO production is dispensable to the cardioprotective effect of AP1. To further confirm this result, we also investigated whether AP1-induced eNOS activation and NO production were inhibited by pretreatment with GR, ER, PI3K/Akt and ERK inhibitors. The results showed that the pretreatment of these inhibitors for 1 h markedly reduced AP1 induced eNOS phosphorylation and NO production (Figures 6B,C), consistent with the effect of NOS inhibitor on NO production. These results support that AP1 induces eNOS activation and NO production via GR and ER dependent RISK signaling pathway in H9c2 cells.
Discussion
In the present study, we descripted that an acid polysaccharides of ginseng AP1, one of the main constituents presenting in ginseng, maintained the mitochondrial function of cardiomyocytes under H/R and down-regulated the activity of LDH and CK, and thus protected cardiomyocytes from H/R injury. AP1 also inhibited the formation of MDA and ROS during the process of reperfusion injury by effectively increasing the activity of SOD, indicating that ginseng polysaccharides can protect cardiomyocytes from free radical injury. Since mitochondrial apoptosis is a major cause of ischemia-reperfusion damage, we examined the effect of ginseng polysaccharides on mitochondrial-related apoptosis pathways. The results demonstrated that ginseng polysaccharides maintained the MMP, increased ATP generation, blocked the releasing of cytochrome C, further inhibited the cleavage of Caspase-3 and 9, and finally counteracted apoptosis induced by ischemia-reperfusion. Meanwhile, ginseng polysaccharides increased the OCR to maintain the energy conservation. Ginseng polysaccharides also induced the expressions of GR and ER which further activated RISK pathway and acted as the main contributor in regulating the viability of cardiomyocytes suffered reperfusion injury. Finally, ginseng polysaccharides regulated endothelial function by increasing eNOS expression, which also greatly contributed to stabilize myocardium environment, reduced cell death, and protected myocardium from injury.
Traditional Chinese medicine has a history of 1000s of years and made significant contributions to the health and well being of the people. Many of TCM have been studied extensively and identified to be safe and effective in treating IHD (Chan, 1995). Among these, ginseng is the most outstanding one. Emerging studies have demonstrated that whole ginseng extract is capable to alleviate cardiomyocytes injury caused by ischemic reperfusion in in vivo and in vitro models (Maffei Facino et al., 1999; Wang et al., 2007; Ahn et al., 2011; Zhou et al., 2011). To better delineate the ingredients responsible for these findings, we isolated the active compounds from ginseng extract by bioassay-guided fractionation. Intriguingly, AP1 was characterized as an acid polysaccharides of ginseng extract, which appears to be the most effective component of ginseng responsible for cardioprotection than the whole ginseng extract in treating H/R-induced cell damage in H9c2 cells. To the best of our knowledge, this is the first study to show that an acid ginseng polysaccharides exerts a cardioprotective effect via activation of RISK pathway and subsequent inhibition of mitochondria-dependent apoptotic pathway. Therefore, this study implies that RISK and mitochondrial apoptosis pathways may serve as a pharmacological target of ginseng in protecting heart, and that AP1 might be a hopeful candidate for the prevention of IHD, particularly for myocardial ischemic reperfusion.
Oxidative stress plays a vital role in the pathophysiological mechanism of ischemic reperfusion (Maulik et al., 1998; Ferrari et al., 2004). Ischemic reperfusion impairs the balance of ROS generation and elimination, and results in oxidative stress and reperfusion (Carpi et al., 2009). ROS can induce cardiomyocyte apoptosis through mitochondria-dependent apoptosis pathway (Circu and Aw, 2010). On the one hand, ROS can damage the mitochondria membrane potential and mitochondrial outer membrane integrity, causing release of apoptogentic proteins into the cytoplasm. The release of cytochrome c-mediated apoptotic enzyme cascade, which triggers the execution of apoptosis in mitochondria (Simon et al., 2000). On the other hand, in response to oxidative stress, JNK and P38 are one of the large downstream cascades of ROS signaling that closely related to cell survival, apoptosis and proliferation (Benhar et al., 2001; Huang et al., 2008; Zhang et al., 2011). Activated JNK and P38 can trigger pro-apoptotic Bax expression, while deactivating pro-survival Bcl-2 protein, thereby stimulating mitochondria-dependent apoptosis (Kim et al., 2006). Therefore, targeting ROS accumulation and mitochondrial dysfunction will be promising for prevention of I/R.
In the present study, we demonstrated that the damage caused by I/R injury can be effectively prevented and reversed by medicinal preconditioning with AP1 through activating the RISK pathway, a classic myocardial protective mechanism consisting of PI3K/Akt and Erk1/2 signaling pathways (Davidson et al., 2006; Hausenloy and Yellon, 2007; Kalakech et al., 2014). In RISK pathway after activating by GR, it induces the phosphorylation of eNOS, and subsequently causes the surge of cardioprotective NO production (Zhou et al., 2011). NO is directly implicated in many cardiovascular syndromes, including vasoconstriction, platelet activation, vasodilation, cell apoptosis, and oxidative stress, etc. (Dinerman et al., 1993; Cannon, 1998; Gao et al., 2002; Casas et al., 2004; Schulz et al., 2004). Among those functions, two aspects were proved to be closely associated with cardioprotective ability. Its anti-oxidative potential as free radical scavenger was the most important one, which was supported by an array of experimental facts: NO can effectively protect the myocardium against free-radical injury (Takano et al., 1998; Hung and Kao, 2004). Additionally, the close relationship between NO and mPTP opening was another important aspect (Hausenloy et al., 2005; Davidson et al., 2006). A serial consequence of mPTP opening including mitochondrial swelling, oxidative phosphorylation decoupling and ATP consumption can be inhibited by NO (Hausenloy et al., 2004), resulting in the enhancement of mitochondrial respiration and mitochondrial protection.
Based on our results, AP1 protected cardiomyocytes by up regulating GR or ER and further trigger the cascade of RISK/eNOS/NO pathways to neutralize ROS generation during H/R process, acting as a mimic of ischemic preconditioning. AP1 also stabilized MMP and maintained ATP supply to keep the mitochondrial membrane intact. Subsequently, cytochrome c release was reduced, and caspase cascade was deactivated, which finally resulted in the recovery of mitochondrial respiration and prevention of mitochondria-dependent apoptosis.
Although the current research demonstrated the cardioprotective effect of AP1 and also showed that this effect is related to the regulation of mitochondrial metabolism and activation of RISK pathway in hypoxia/reoxygenized H9c2 cells, there are still some limitations and will be resolved in future research. For example, it is not clear whether this effect of AP1 can be repeated in animal models and if other mechanisms involve in this effect, therefore, mice with left anterior descending coronary artery ligation can be a powerful model to address the in vivo effects and therapeutic potential of AP1 treatment. In addition, although the use of pharmacological inhibitors of GR, ER, PI3K/Akt, and ERK supported the involvements of RISK pathway in the effect of AP1, knock down experiments in in vitro cultured cells or knock out mice model would definitely further confirm their roles in this regard. It is also interested to know whether repeated dosing could give a better protection to cardiomyocytes and/or animal hearts undertaken ischemia/reperfusion injury insult. Furthermore, the influence of AP1 on other cell types involved in the pathogenesis of IHDs, such as endothelial cells and macrophages, will be investigated in future research to elaborate the action mechanisms of AP1 from a broader view. With the results from these researches, we could have a better and comprehensive understanding to the efficacy of AP1 on IHDs.
Conclusion
An acidic polysaccharides fraction (AP1) derived from ginseng extract with cardioprotective function was discovered for the first time. Mechanistic studies demonstrated that the cardioprotective effect of AP1 involves receptor-mediated activation of RISK/eNOS/NO pathway and modulation of mitochondrial function and metabolism for the first time (Figure 7). Although the ginseng polysaccharide is frequently neglected in cardiovascular study, its potential as a novel natural food supplements for the prevention of IHD can be explored further in future.
FIGURE 7. Possible mechanism of the cardioprotective effect of AP1 in H9c2 cells exposed to H/R injury. AP1 induced the expression of GR and ER, which further activated reperfusion injury salvage kinase (RISK, including PI3K/Akt and EEK1/2) pathway. Phosphorylated PI3K/Akt and ERK in turn up-regulated the expression level of eNOS, and further increased NO generation. In addition, AP1 also inhibited the phosphorylation of JNK and p38 and in turn enhanced the ratio of Bcl-2/Bax, which ultimately inhibited the mitochondria-dependent apoptosis pathways to abolish cell death.
Author Contributions
HZ, PL, and LL designed the experiment. Y-HZ, Q-BH, G-TD, R-QY, X-CR, and J-XL performed the experiments. Y-HZ, Q-BH, and HZ analyzed the data. Y-HZ and HZ wrote the manuscript.
Funding
This research was financially supported by the Macao Science and Technology Development Fund (Project No: 037/2014/A1).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Abbreviations
AP1, acidic polysaccharides fraction of ginseng; Bax, Bcl-2-associated X protein; Bcl-2, B-cell lymphoma 2; CK, creatine kinase; DMEM, dulbecco’s modified Eagle’s medium; DZ, diazoxide; eNOS, endothelial nitric oxide synthase; ER, estrogen receptor; ERK1/2, extracellular signal-regulated kinases; FBS, fetal bovine serum; Gal A, D-galacturonic acid monohydrate; ginseng, Panax ginseng; Glc, D-glucose; GR, glucocorticoid receptor; H/R, hypoxia/reoxygenation; HPGPC, high performance gel filtration chromatography; HPLC, high performance liquid chromatography; HSCCC, high speed counter current chromatography; IHD, ischemic heart diseases; iNOS, inducible nitric oxide synthase; JNK, c-Jun N-terminal kinases; KRB, Krebs-Ringer Bicarbonate; LDH, lactate dehydrogenase; MDA, malondialdehyde; MMP, mitochondrial membrane potential; MVS, mitochondrial Viability Stain; NO, nitric oxide; OCR, oxygen consumption rate; p-eNOS, phosphorylated endothelial nitric oxide synthase; p-ERK1/2, phosphorylated extracellular signal-regulated kinases; p-JNK, phosphorylated c-Jun N-terminal kinases; PMP, 1-pheny-3-methy-5-pyrazolne; RISK, reperfusion injury salvage kinase; ROS, reactive oxygen species; SOD, superoxide dismutase; TCM, traditional Chinese medicine; TFA, trifluoroacetic acid; TLC, thin layer chromatography.
References
Ahn, C. M., Hong, S. J., Choi, S. C., Park, J. H., Kim, J. S., and Lim, D. S. (2011). Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction. Phytother. Res. 25, 239–249. doi: 10.1002/ptr.3250
Attele, A. S., Wu, J. A., and Yuan, C. S. (1999). Ginseng pharmacology - multiple constituents and multiple actions. Biochem. Pharmacol. 58, 1685–1693. doi: 10.1016/S0006-2952(99)00212-9
Becker, L. B. (2004). New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61, 461–470. doi: 10.1016/j.cardiores.2003.10.025
Benhar, M., Dalyot, I., Engelberg, D., and Levitzki, A. (2001). Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell. Biol. 21, 6913–6926. doi: 10.1128/Mcb.21.20.6913-6926.2001
Blumenkrantz, N., and Asboe-Hansen, G. (1973). New method for quantitative determination of uronic acids. Anal. Biochem. 54, 484–489. doi: 10.1016/0003-2697(73)90377-1
Buontempo, F., Ersahin, T., Missiroli, S., Senturk, S., Etro, D., Ozturk, M., et al. (2011). Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status. Invest. New Drugs 29, 1303–1313. doi: 10.1007/s10637-010-9486-3
Burwell, L. S., and Brookes, P. S. (2008). Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury. Antioxid. Redox Signal. 10, 579–599. doi: 10.1089/ars.2007.1845
Cannon, R. O. III. (1998). Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin. Chem. 44(8 Pt 2), 1809–1819.
Carpi, A., Menabo, R., Kaludercic, N., Pelicci, P., Di Lisa, F., and Giorgio, M. (2009). The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. Biochim. Biophys. Acta 1787, 774–780. doi: 10.1016/j.bbabio.2009.04.001
Casas, J. P., Bautista, L. E., Humphries, S. E., and Hingorani, A. D. (2004). Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109, 1359–1365. doi: 10.1161/01.CIR.0000121357.76910.A3
Castro, I. A., Barroso, L. P., and Sinnecker, P. (2005). Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach. Am. J. Clin. Nutr. 82, 32–40. doi: 10.1093/ajcn/82.1.32
Chan, K. (1995). Progress in traditional Chinese medicine. Trends Pharmacol. Sci. 16, 182–187. doi: 10.1016/S0165-6147(00)89019-7
Chang, C. C., Chang, Y. C., Hu, W. L., and Hung, Y. C. (2016). Oxidative stress and Salvia miltiorrhiza in aging-associated cardiovascular diseases. Oxid. Med. Cell. Longev. 2016:4797102. doi: 10.1155/2016/4797102
Chen, X. (1996). Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin. Exp. Pharmacol. Physiol. 23, 728–732. doi: 10.1111/j.1440-1681.1996.tb01767.x
Chen, X. P., Guan, T., Li, C., Shang, H. F., Cui, L. Y., Li, X. M., et al. (2012). SOD1 aggregation in astrocytes following ischemia/reperfusion injury: a role of NO-mediated S-nitrosylation of protein disulfide isomerase (PDI). J. Neuroinflammation 9:237. doi: 10.1186/1742-2094-9-237
Circu, M. L., and Aw, T. Y. (2010). Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 48, 749–762. doi: 10.1016/j.freeradbiomed.2009.12.022
Davidson, S. M., Hausenloy, D., Duchen, M. R., and Yellon, D. M. (2006). Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int. J. Biochem. Cell Biol. 38, 414–419. doi: 10.1016/j.biocel.2005.09.017
Dinerman, J. L., Lowenstein, C. J., and Snyder, S. H. (1993). Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease. Circ. Res. 73, 217–222. doi: 10.1161/01.RES.73.2.217
Dong, G., Chen, T., Ren, X., Zhang, Z., Huang, W., Liu, L., et al. (2016). Rg1 prevents myocardial hypoxia/reoxygenation injury by regulating mitochondrial dynamics imbalance via modulation of glutamate dehydrogenase and mitofusin 2. Mitochondrion 26, 7–18. doi: 10.1016/j.mito.2015.11.003
Dubois, M., Gilles, K. A., Hamilton, J. K., Rebers, P., and Smith, F. (1956). Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350–356. doi: 10.1021/ac60111a017
Duicu, O. M., Scurtu, I., Popescu, R., Sturza, A., Coricovac, D., Danila, M. D., et al. (2015). Assessment of the effects of methylene blue on cellular bioenergetics in H9c2 cells. Rev. Chim. 66, 519–522.
Dunn, E. F., Fearns, R., and Connor, J. H. (2009). Akt Inhibitor Akt-IV Blocks Virus Replication through an Akt-Independent Mechanism. J. Virol. 83, 11665–11672. doi: 10.1128/JVI.01092-09
Ferrari, R., Guardigli, G., Mele, D., Percoco, G. F., Ceconi, C., and Curello, S. (2004). Oxidative stress during myocardial ischaemia and heart failure. Curr. Pharm. Des. 10, 1699–1711. doi: 10.2174/1381612043384718
Gago-Dominguez, M., Castelao, J. E., Yuan, J. M., Ross, R. K., and Yu, M. C. (2002). Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 13, 287–293. doi: 10.1023/A:1015044518505
Gao, F., Gao, E., Yue, T. L., Ohlstein, E. H., Lopez, B. L., Christopher, T. A., et al. (2002). Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105, 1497–1502. doi: 10.1161/01.CIR.0000012529.00367.0F
Hausenloy, D., Wynne, A., Duchen, M., and Yellon, D. (2004). Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 109, 1714–1717. doi: 10.1161/01.CIR.0000126294.81407.7D
Hausenloy, D. J., Tsang, A., Mocanu, M. M., and Yellon, D. M. (2005). Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am. J. Physiol. Heart Circ. Physiol. 288, H971–H976. doi: 10.1152/ajpheart.00374.2004
Hausenloy, D. J., and Yellon, D. M. (2007). Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail. Rev. 12, 217–234. doi: 10.1007/s10741-007-9026-1
Hausenloy, D. J., and Yellon, D. M. (2013). Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 123, 92–100. doi: 10.1172/JCI62874
He, Z. M., Wang, X. H., Li, G. F., Zhao, Y. J., Zhang, J., Niu, C. H., et al. (2015). Antioxidant activity of prebiotic ginseng polysaccharides combined with potential probiotic Lactobacillus plantarum C88. Int. J. Food Sci. Technol. 50, 1673–1682. doi: 10.1111/ijfs.12824
Henn, M. C., Janjua, M. B., Zhang, H., Kanter, E. M., Makepeace, C. M., Schuessler, R. B., et al. (2015). Diazoxide cardioprotection is independent of adenosine triphosphate-sensitive potassium channel Kir6.1 subunit in response to stress. J. Am. Coll. Surg. 221, 319–325. doi: 10.1016/j.jamcollsurg.2015.02.014
Huang, J., Wu, L. J., Tashiro, S., Onodera, S., and Ikejima, T. (2008). Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways. J. Pharmacol. Sci. 107, 370–379. doi: 10.1254/jphs.08044FP
Hung, K. T., and Kao, C. H. (2004). Nitric oxide acts as an antioxidant and delays methyl jasmonate-induced senescence of rice leaves. J. Plant Physiol. 161, 43–52. doi: 10.1078/0176-1617-01178
Janjua, M. B., Makepeace, C. M., Anastacio, M. M., Schuessler, R. B., Nichols, C. G., and Lawton, J. S. (2014). Cardioprotective benefits of adenosine triphosphate-sensitive potassium channel opener diazoxide are lost with administration after the onset of stress in mouse and human myocytes. J. Am. Coll. Surg. 219, 803–813. doi: 10.1016/j.jamcollsurg.2014.05.010
Jiang, M., Kang, L., Wang, Y., Zhao, X., Liu, X., Xu, L., et al. (2014). A metabonomic study of cardioprotection of ginsenosides, schizandrin, and ophiopogonin D against acute myocardial infarction in rats. BMC Complement Altern. Med. 14:350. doi: 10.1186/1472-6882-14-350
Joshi, D. C., and Bakowska, J. C. (2011). Determination of mitochondrial membrane potential and reactive oxygen species in live rat cortical neurons. J. Vis. Exp. 51:2704. doi: 10.3791/2704
Kalakech, H., Hibert, P., Prunier-Mirebeau, D., Tamareille, S., Letournel, F., Macchi, L., et al. (2014). RISK and SAFE signaling pathway involvement in Apolipoprotein A-I-Induced cardioprotection. PLoS One 9:e107950. doi: 10.1371/journal.pone.0107950
Kalogeris, T., Bao, Y., and Korthuis, R. J. (2014). Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning. Redox Biol. 2, 702–714. doi: 10.1016/j.redox.2014.05.006
Khan, K. K., He, Y. Q., Correia, M. A., and Halpert, J. R. (2002). Differential oxidation of mifepristone by cytochromes P450 3A4 and 3A5: Selective inactivation of P450 3A4. Drug Metab. Dispos. 30, 985–990. doi: 10.1124/dmd.30.9.985
Kim, B. J., Ryu, S. W., and Song, B. J. (2006). JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J. Biol. Chem. 281, 21256–21265. doi: 10.1074/jbc.M510644200
Kim, S. H., and Park, K. S. (2003). Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacol. Res. 48, 511–513. doi: 10.1016/S1043-6618(03)00189-0
Lee, C. H., and Kim, J. H. (2014). A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J. Ginseng Res. 38, 161–166. doi: 10.1016/j.jgr.2014.03.001
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., et al. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479–489. doi: 10.1016/S0092-8674(00)80434-1
Lim, T. S., Na, K., Choi, E. M., Chung, J. Y., and Hwang, J. K. (2004). Immunomodulating activities of polysaccharides isolated from Panax ginseng. J. Med. Food 7, 1–6. doi: 10.1089/109662004322984626
Liu, C. X., and Xiao, P. G. (1992). Recent advances on ginseng research in China. J. Ethnopharmacol. 36, 27–38. doi: 10.1016/0378-8741(92)90057-X
Loscalzo, J., and Welch, G. (1995). Nitric oxide and its role in the cardiovascular system. Prog. Cardiovasc. Dis. 38, 87–104. doi: 10.1016/S0033-0620(05)80001-5
Lu, C., Hua, F., Liu, L., Ha, T. Z., Kalbfleisch, J., Schweitzer, J., et al. (2010). Scavenger receptor class-A has a central role in cerebral ischemia-reperfusion injury. J. Cereb. Blood Flow Metab. 30, 1972–1981. doi: 10.1038/jcbfm.2010.59
Lu, J. M., Yao, Q. Z., and Chen, C. Y. (2009). Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr. Vasc. Pharmacol. 7, 293–302. doi: 10.2174/157016109788340767
Maffei Facino, R., Carini, M., Aldini, G., Berti, F., and Rossoni, G. (1999). Panax ginseng administration in the rat prevents myocardial ischemia-reperfusion damage induced by hyperbaric oxygen: evidence for an antioxidant intervention. Planta Med. 65, 614–619. doi: 10.1055/s-1999-14034
Maulik, N., Yoshida, T., and Das, D. K. (1998). Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radic. Biol. Med. 24, 869–875. doi: 10.1016/S0891-5849(97)00388-2
Moens, A. L., Claeys, M. J., Timmermans, J. P., and Vrints, C. J. (2005). Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int. J. Cardiol. 100, 179–190. doi: 10.1016/j.ijcard.2004.04.013
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., et al. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787–790. doi: 10.1038/35008121
Park, S., Kim, B., Kim, J., Won, K. J., Lee, S., Kwon, S., et al. (2003). Tamoxifen induces vasorelaxation via inhibition of mitogen-activated protein kinase in rat aortic smooth muscle. J. Vet. Med. Sci. 65, 1155–1160. doi: 10.1292/jvms.65.1155
Petrosillo, G., Colantuono, G., Moro, N., Ruggiero, F. M., Tiravanti, E., Di Venosa, N., et al. (2009). Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am. J. Physiol. Heart Circ. Physiol. 297, H1487–H1493. doi: 10.1152/ajpheart.00163.2009
Porter, A. G., and Janicke, R. U. (1999). Emerging roles of caspase-3 in apoptosis. Cell Death. Differ. 6, 99–104. doi: 10.1038/sj.cdd.4400476
Sardao, V. A., Oliveira, P. J., Holy, J., Oliveira, C. R., and Wallace, K. B. (2009). Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets. Cell Biol. Toxicol 25, 227–243. doi: 10.1007/s10565-008-9070-1
Schulz, R., Kelm, M., and Heusch, G. (2004). Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc. Res. 61, 402–413. doi: 10.1016/j.cardiores.2003.09.019
Shahidi, F. (2004). Functional foods: their role in health promotion and disease prevention. J. Food Sci. 69, R146–R149. doi: 10.1111/j.1365-2621.2004.tb10727.x
Shen, H. M., and Liu, Z. G. (2006). JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 40, 928–939. doi: 10.1016/j.freeradbiomed.2005.10.056
Shi, X., Lin, X., Yao, C., Shen, L., and Feng, Y. (2015). Injectable long-acting in situ forming systems for Radix Ophiopogonis polysaccharide. Int. J. Biol. Macromol. 72, 553–559. doi: 10.1016/j.ijbiomac.2014.09.009
Shumilova, T. E., Nozdrachev, A. D., and Fedorova, M. A. (2014). Role of inorganic nitrite and nitric oxide in the function of cardiovascular system. Ross. Fiziol. Zh. Im. I.M. Sechenova 100, 301–317.
Simon, H. U., Haj-Yehia, A., and Levi-Schaffer, F. (2000). Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415–418. doi: 10.1023/A:1009616228304
Song, M., Huang, L., Zhao, G., and Song, Y. (2013). Beneficial effects of a polysaccharide from Salvia miltiorrhiza on myocardial ischemia-reperfusion injury in rats. Carbohydr. Polym. 98, 1631–1636. doi: 10.1016/j.carbpol.2013.08.020
Sun, C., Chen, Y., Li, X., Tai, G., Fan, Y., and Zhou, Y. (2014). Anti-hyperglycemic and anti-oxidative activities of ginseng polysaccharides in STZ-induced diabetic mice. Food Funct. 5, 845–848. doi: 10.1039/c3fo60326a
Takano, H., Tang, X. L., Qiu, Y., Guo, Y., French, B. A., and Bolli, R. (1998). Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ. Res. 83, 73–84. doi: 10.1161/01.RES.83.1.73
Takano, H., Zou, Y., Hasegawa, H., Akazawa, H., Nagai, T., and Komuro, I. (2003). Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases. Antioxid. Redox. Signal. 5, 789–794. doi: 10.1089/152308603770380098
Todd, J. R., Scurr, L. L., Becker, T. M., Kefford, R. F., and Rizos, H. (2014). The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma. Oncogene 33, 236–245. doi: 10.1038/onc.2012.562
Turner, P. J., Maggs, J. R. L., and Foreman, J. C. (2000). Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway. Br. J. Pharmacol. 131, 363–369. doi: 10.1038/sj.bjp.0703561
Vogler, B. K., Pittler, M. H., and Ernst, E. (1999). The efficacy of ginseng. A systematic review of randomised clinical trials. Eur. J. Clin. Pharmacol. 55, 567–575. doi: 10.1007/s002280050674
Wang, C. Z., Mehendale, S. R., and Yuan, C. S. (2007). Commonly used antioxidant botanicals: active constituents and their potential role in cardiovascular illness. Am. J. Chin. Med. 35, 543–558. doi: 10.1142/S0192415x07005053
Wang, L., Yao, C., Wu, F., Lin, X., Shen, L., and Feng, Y. (2015). Targeting delivery of Radix Ophiopogonis polysaccharide to ischemic/reperfused rat myocardium by long-circulating macromolecular and liposomal carriers. Int. J. Nanomedicine 10, 5729–5737. doi: 10.2147/IJN.S89445
World Health Organization (2014). The top 10 causes of death [Online]. Available at: http://www.who.int/mediacentre/factsheets/fs310/en/
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326–1331. doi: 10.1126/science.270.5240.1326
Xu, J., Li, S. L., Yue, R. Q., Ko, C. H., Hu, J. M., Liu, J., et al. (2014). A novel and rapid HPGPC-based strategy for quality control of saccharide-dominant herbal materials: Dendrobium officinale, a case study. Anal. Bioanal. Chem. 406, 6409–6417. doi: 10.1007/s00216-014-8060-9
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., et al. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129–1132. doi: 10.1126/science.275.5303.1129
Yellon, D. M., and Hausenloy, D. J. (2007). Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121–1135. doi: 10.1056/NEJMra071667
Zhang, J., Lu, S., Wang, H., and Zheng, Q. (2013a). Protective role of Aralia elata polysaccharide on mercury(II)-induced cardiovascular oxidative injury in rats. Int. J. Biol. Macromol. 59, 301–304. doi: 10.1016/j.ijbiomac.2013.04.047
Zhang, J., Wang, H., Xue, Y., and Zheng, Q. (2013b). Cardioprotective and antioxidant activities of a polysaccharide from the root bark of Aralia elata (Miq.) Seem. Carbohydr. Polym. 93, 442–448. doi: 10.1016/j.carbpol.2012.12.048
Zhang, Y., Liao, H., Zhong, S., Gao, F., Chen, Y., Huang, Z., et al. (2015). Effect of N-n-butyl haloperidol iodide on ROS/JNK/Egr-1 signaling in H9c2 cells after hypoxia/reoxygenation. Sci. Rep. 5:11809. doi: 10.1038/srep11809
Zhang, Z., Teruya, K., Eto, H., and Shirahata, S. (2011). Fucoidan extract induces apoptosis in MCF-7 cells via a mechanism involving the ROS-dependent JNK activation and mitochondria-mediated pathways. PLoS One 6:e27441. doi: 10.1371/journal.pone.0027441
Zhou, H., Hou, S. Z., Luo, P., Zeng, B., Wang, J. R., Wong, Y. F., et al. (2011). Ginseng protects rodent hearts from acute myocardial ischemia–reperfusion injury through GR/ER-activated RISK pathway in an endothelial NOS-dependent mechanism. J. Ethnopharmacol. 135, 287–298. doi: 10.1016/j.jep.2011.03.015
Keywords: Panax ginseng, acidic polysaccharides, cardioprotection, mitochondrial metabolism, RISK pathway
Citation: Zuo Y-H, Han Q-B, Dong G-T, Yue R-Q, Ren X-C, Liu J-X, Liu L, Luo P and Zhou H (2018) Panax ginseng Polysaccharide Protected H9c2 Cardiomyocyte From Hypoxia/Reoxygenation Injury Through Regulating Mitochondrial Metabolism and RISK Pathway. Front. Physiol. 9:699. doi: 10.3389/fphys.2018.00699
Received: 05 January 2018; Accepted: 18 May 2018;
Published: 15 June 2018.
Edited by:
Jing-Yan Han, Peking University, ChinaReviewed by:
Suowen Xu, University of Rochester, United StatesHanrui Zhang, Columbia University, United States
Copyright © 2018 Zuo, Han, Dong, Yue, Ren, Liu, Liu, Luo and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hua Zhou, aHpob3VAbXVzdC5lZHUubW8= Pei Luo, cGx1b0BtdXN0LmVkdS5tbw==